Wellness Daily Nauru: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wellness Daily Nauru.

Press releases published on July 16, 2026

Jul. 16, 2026

Umoja Biopharma Announces FDA Clearance of IND Application for UB-VV400, the Industry’s First Known CD22-Directed In Vivo CAR T Cell Therapy for Relapsed/Refractory B Cell Malignancies

Indeterminate GlobeNewswire

Jul. 16, 2026

Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program

Indeterminate GlobeNewswire

Jul. 16, 2026

CDT Equity Inc. Announces Reverse Stock Split

Indeterminate GlobeNewswire

Jul. 16, 2026

New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation

Indeterminate GlobeNewswire

Jul. 16, 2026

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026

Indeterminate GlobeNewswire

Jul. 16, 2026

Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform

Indeterminate GlobeNewswire

Jul. 16, 2026

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

Indeterminate GlobeNewswire

Jul. 16, 2026

Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders

Indeterminate GlobeNewswire

Jul. 16, 2026

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 16, 2026

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025

Indeterminate GlobeNewswire

Jul. 16, 2026

Diagonal Therapeutics Announces First Patient Dosed in Phase 1/2 DIAMOND Clinical Trial of DIAG723 for Hereditary Hemorrhagic Telangiectasia (HHT)

Indeterminate GlobeNewswire

Jul. 16, 2026

Immuron FY26 Sales - Four Consecutive Quarters of Growth over Prior Year

Indeterminate GlobeNewswire

Jul. 16, 2026

BienRaíz Launches 240 mg Magnesium Glycinate Supplement, Expanding Its Daily Wellness Portfolio with Targeted Mineral Support

Indeterminate GlobeNewswire

Jul. 16, 2026

Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals

Indeterminate GlobeNewswire

Jul. 16, 2026

Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development

Indeterminate GlobeNewswire

Jul. 16, 2026

argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026

Indeterminate GlobeNewswire